Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acquisition
Biotech
Chimerix had 8 suitors: Why Jazz won out
Chimerix considered the downward market trend for biopharma and a general volatility tied to escalating global tensions when assessing Jazz's offer.
Gabrielle Masson
Mar 21, 2025 5:17pm
Cell therapy biotech axes cancer trial, turns to autoimmune
Mar 19, 2025 5:35pm
Hookipa walks back Poolbeg purchase plan
Feb 20, 2025 1:34pm
Clinical trial org Flourish Research buys Diablo
Feb 19, 2025 6:00pm
Michigan CRO buys Northern Irish cloud-based data science firm
Feb 12, 2025 2:33pm
N-Power links with Syapse, adds oncologists to research network
Jan 14, 2025 1:33pm